Both in Surgical Instruments
Sight Sciences vs Neuropace
Over the past year SGHT returned +85.5% and NPCE returned +32.0%; their daily moves had a correlation of 0.29.
SGHT +85.5% NPCE +32.0%Growth of $1, one year, split-adjusted
| Metric | SGHT | NPCE |
|---|---|---|
| Price | $9.46 | $12.41 |
| Market cap | $521.1M | $426.0M |
| Today | +1.50% | +0.89% |
| 1 month | +10.9% | −2.3% |
| 6 months | +124.2% | −26.6% |
| Year to date | +19.3% | −19.6% |
| 1 year | +86.2% | +25.9% |
| Revenue growth (YoY) | +19.5% | +17.1% |
| Gross margin | 91.4% | 82.8% |
| Net margin | −19.0% | −27.2% |
| P/E (TTM) | — | — |
| Price / sales | 6.3× | 4.3× |
| Net cash | $39.0M | -$7.3M |
| Dividend yield | — | — |
| Volatility (60d) | 44.9% | 40.2% |
| Short % of float | 3.4% | 3.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).